International stock news

Rss Today on Proactive AU

2014-10-02

Admedus vaccine for herpes has success; moves to next clinical trial

 
Final results from the Phase I trial, which reached its primary endpoint of safety, for Admedus’ HSV-2 vaccine show that 95% of the participants had a positive T-cell response. The encouraging results support the progression of the vaccine candidate into Phase II clinical studies, which is expected to begin by the end of 2014.
FULL ARTICLE

 

Rss Today on Proactive UK

2014-10-02

Range Resources' new financing puts right years of under investment in Trinidad, CEO says

 
Speaking with Proactive Investors chief executive Rory Scott Russell said Tuesday’s results and the financing represents a final line in the sand between Range and what he hopes will be viewed as legacy problems.
FULL ARTICLE

 

Rss Today on Proactive US

2014-10-02

Wall Street plunges on worries over rising interest rates

 
U.S. stocks slid Wednesday, continuing their sell off after an upbeat private sector ADP jobs report and September manufacturing data prompted concerns about the Fed raising rates sooner rather than later.
FULL ARTICLE